Roger Song
Stock Analyst at Jefferies
(0.58)
# 3,746
Out of 4,814 analysts
45
Total ratings
21.62%
Success rate
-29.18%
Average return
Main Sectors:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Upgrades: Buy | $1 → $2 | $0.64 | +212.50% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $2.06 | +191.26% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $1.64 | +326.83% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $168.53 | +45.37% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $5.92 | +339.19% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.24 | +61.94% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $3.87 | +81.11% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $7.96 | +138.69% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $5.88 | +376.19% | 2 | Nov 21, 2024 | |
| ACRS Aclaris Therapeutics | Upgrades: Buy | $2 → $7 | $1.13 | +519.47% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $42.24 | +110.70% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $6.00 | +316.67% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $9.32 | +339.91% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $8.96 | +290.63% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $20.21 | +97.92% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.11 | +189.39% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $30.50 | +322.95% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $0.65 | +1,125.11% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $71.73 | +35.23% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $15.99 | +350.28% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $23.83 | +361.60% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $4.54 | +670.93% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.84 | +967.36% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $3.23 | +147.68% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.22 | +1,680.15% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.53 | +3,875.01% | 1 | Sep 2, 2020 |
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $1 → $2
Current: $0.64
Upside: +212.50%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.06
Upside: +191.26%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $1.64
Upside: +326.83%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $168.53
Upside: +45.37%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $5.92
Upside: +339.19%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.24
Upside: +61.94%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $3.87
Upside: +81.11%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $7.96
Upside: +138.69%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $5.88
Upside: +376.19%
Aclaris Therapeutics
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.13
Upside: +519.47%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $42.24
Upside: +110.70%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $6.00
Upside: +316.67%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $9.32
Upside: +339.91%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $8.96
Upside: +290.63%
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $20.21
Upside: +97.92%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $3.11
Upside: +189.39%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $30.50
Upside: +322.95%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $0.65
Upside: +1,125.11%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $71.73
Upside: +35.23%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $15.99
Upside: +350.28%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $23.83
Upside: +361.60%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $4.54
Upside: +670.93%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.84
Upside: +967.36%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $3.23
Upside: +147.68%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.22
Upside: +1,680.15%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.53
Upside: +3,875.01%